Mankind Pharma Faces Persistent Stock Decline Amid Broader Market Volatility

Mankind Pharma, a key player in the pharmaceuticals and drugs sector, has faced notable challenges in its stock performance recently. On January 13, 2025, the stock declined by 3.95%, underperforming its sector by 3.13%. Over the last four days, Mankind Pharma has experienced a cumulative drop of 9.55%, indicating a persistent downward trend.
The stock opened the day down 2.88% and reached an intraday low of Rs 2625, reflecting a 4.51% decrease. Despite these short-term challenges, Mankind Pharma's stock remains above its 100-day and 200-day moving averages, suggesting some level of long-term stability. However, it is currently trading below its 5-day, 20-day, and 50-day moving averages, highlighting short-term volatility.

In the context of the broader market, Mankind Pharma's one-day performance of -4.26% stands in contrast to the Sensex's decline of only 0.69%. Over the past month, the company's stock has decreased by 0.43%, while the Sensex has experienced a more substantial drop of 6.44%.